Bone and Joint Infection
Conditions
Keywords
prosthesis joint infection, relapse
Brief summary
Bone and joint infections (BJI), although infrequent (prevalence of 70 per 100,000 in France), have a significant economic and clinical impact. Between 2008 and 2013, the prevalence of BJI increased and infections involving joint prosthesis (PJI) represent a third of BJI in France. They are most often post-operative and more expensive than native IOAs. This study aims to describe PJI and understand the failure mechanisms of PJI in order to improve their management.
Interventions
patients having had a PJI managed at the CRIOAc Lyon, with or without relapse
Sponsors
Study design
Eligibility
Inclusion criteria
* patients having had a PJI between 2018 and 2020
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| description of surgical treatment | between 2018 and 2020 | type of surgery: 1-step exchange, 2- step exchange, DAIR |
| description of antibiotic used | between 2018 and 2020 | type of antibiotic : name |
| description of antibiotic treatment | between 2018 and 2020 | duration of antibiotic treatment |
| rate of PJI | between 2018 and 2020 | proportion of PJI among all BJI |
| Description of PJI | between 2018 and 2020 | acute/chronic |
| Description of type of prosthesis PJI | between 2018 and 2020 | number of prosthesis |
| Description of patients having had a PJI | between 2018 and 2020 | type of patients: age |
| Description of comorbidities of patients having had a PJI | between 2018 and 2020 | type of comorbidities.. |
| rate of bacteria | between 2018 and 2020 | epidemiologic description of PJI |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| description of the failure | between 2018 and 2020 | type of failure : persistence or surinfection and management of failure |
| rate of failure | between 2018 and 2020 | proportion of patients having a failure |
Countries
France